Jarrow Formulas Inc   Report issue

For profit Phase 2 Phase 3
Founded: Los Angeles CA United States (1977)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2004
NCT00300937
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Jarrow Formulas Inc | PomeGreat

Active Ingredients

Drugs in Phase 3 Trials (1)

ubiquinone (1 trial)

Drugs in Phase 2 Trials (2)

acetylcysteine (mucomyst) (1 trial)

alpha-lipoic acid (1 trial)

Drugs in Other Trials (1)

pomegranate (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 2)

Cognitive Dysfunction (Phase 2)

Metabolic Syndrome (Phase 2)

Ovarian Neoplasms (Phase 2)

Pre-Eclampsia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4